About 76% of the US population has received at least one shot; less than 65% of all Americans are fully vaccinated
Sanofi-GSK's shot relies on a conventional protein-based approach, compared with the newer mRNA technology used in established Covid-19 vaccines from Pfizer-BioNTech and Moderna
Thermo Fisher had already partnered with Moderna last year to help scale up production of its Covid vaccine, branded as Spikevax
As per the health ministry, with the administration of 36,28,578 vaccine doses in the last 24 hours, India's Covid-19 vaccination coverage has exceeded 1,75,03,86,834
As part of the nationwide vaccination drive, the Centre has been supporting the states and UTs by providing them Covid-19 vaccines free of cost
Mandaviya also said that the world is astonished by India's vaccination coverage which has reached almost 175 crore, adding that the third Covid-19 wave is on the decline
Moderna chief executive Stephane Bancel said in an interview the company aimed to have a booster ready by August 2022, before next autumn when he said more vulnerable people may need it
Many more vaccines are expected to be rejected as African nations and Covax said that from January they would not accept vaccines with less than two-and-a-half months' shelf life
ZyCoV-D is already approved by the regulator for use in children aged 12 and more
Claiming inspiration from truckers' anti-vaccine mandate demonstrations in Canada, the protesters have also blocked several streets around parliament with their trucks, vans and motorcycles
The company is rolling back a mask requirement it put back into effect during the Omicron surge in December
Indian Council of Medical Research Director General, Dr Balram Bhargava, said that this is another vaccine which really establishes that India is heading towards becoming a vaccine superpower
Omicron emerged as a variant of concern only in November 2021, but all the mutations it contains, except one, had been described before that
The ICMR has spent around Rs 35 crore in research and development of covid vaccine Covaxin
Pfizer said Tuesday that it expects adjusted earnings in the new year to range from USD 6.35 to USD 6.55 per share on USD 98 billion to USD 102 billion in revenue
Sputnik V is a heterogeneous vaccine which uses two different components in its two doses
The government is yet to decide on which segment of beneficiaries this new vaccine would be administered
The study, published recently in the journal Nature Medicine, tracked the antibodies of vaccinated and recovered individuals for two years
Among several key clinical insights, researchers found that symptoms start to develop very fast, on average about two days after contact with the virus
It said the Centre had proactively advised all state governments to review the availability of vaccines to ensure that the wastage of doses is reduced to a minimum